Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

Mechanism’s Mojo ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

FDA Approves a Second Pulsed-Field Ablation System

News Daily News

FDA Approves a Second Pulsed-Field Ablation System

January 31, 2024

Top Endovascular News of 2023

News Daily News

Top Endovascular News of 2023

December 28, 2023

Symplicity Spyral Approved: FDA Clears Second Renal Denervation System

News Daily News

Symplicity Spyral Approved: FDA Clears Second Renal Denervation System

November 20, 2023

FDA Approves Paradise Renal Denervation System: What Comes Next?

News Daily News

FDA Approves Paradise Renal Denervation System: What Comes Next?

November 08, 2023

FDA Approves Colchicine for Decreasing CV Events

News Daily News

FDA Approves Colchicine for Decreasing CV Events

June 20, 2023

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

News Daily News

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Michael O'Riordan

December 14, 2022

FDA Approves Finerenone for Adults With CKD and Type 2 Diabetes

News Daily News

FDA Approves Finerenone for Adults With CKD and Type 2 Diabetes

Yael L. Maxwell

July 09, 2021

FDA Approves Dapagliflozin for CKD Patients

News Daily News

FDA Approves Dapagliflozin for CKD Patients

Michael O'Riordan

May 03, 2021

FDA Grants Cardiac MR Indication for Gadavist Contrast Injection

News Daily News

FDA Grants Cardiac MR Indication for Gadavist Contrast Injection

July 16, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.